コネチカット州における大うつ病性障害の臨床試験
コネチカット州内の拠点で、大うつ病性障害に関する16件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- UConn Health Center, Farmington
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/25更新 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Connecticut Health Center, Farmington
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Connecticut School of Medicine Psychiatry Department, Farmington
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/08/03更新 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
被験者募集中第2相
21歳〜65歳 · 全性別 · 2026/05/06更新 · NCT05786066Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- Yale University, New Haven
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/05/06更新 · NCT05915013Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383Imaging Depression in Parkinson's Disease
- Yale University, New Haven
被験者募集中第2相健康なボランティア歓迎
40歳〜80歳 · 全性別 · 2026/03/10更新 · NCT06402955Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #122, Cromwell
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/01/20更新 · NCT06633016ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。